PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
48.13%
Revenue growth above 1.5x RUN's 2.50%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
268.96%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
22.43%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
7.68%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
42.14%
Net income growth above 1.5x RUN's 10.59%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
41.79%
EPS growth at 75-90% of RUN's 52.94%. Bill Ackman would push for improved profitability or share repurchases to catch up.
41.79%
Diluted EPS growth at 75-90% of RUN's 52.94%. Bill Ackman would expect further improvements in net income or share count reduction.
0.05%
Share reduction more than 1.5x RUN's 0.66%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.05%
Diluted share reduction more than 1.5x RUN's 2.10%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
83.55%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
54.77%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
15.45%
10Y revenue/share CAGR under 50% of RUN's 88.81%. Michael Burry would suspect a lasting competitive disadvantage.
-36.17%
Negative 5Y CAGR while RUN stands at 88.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.06%
Negative 3Y CAGR while RUN stands at 88.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6.52%
Negative 10Y OCF/share CAGR while RUN stands at 29.82%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
28.49%
5Y OCF/share CAGR is similar to RUN's 29.82%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
22.80%
3Y OCF/share CAGR at 75-90% of RUN's 29.82%. Bill Ackman would press for improvements in margin or overhead to catch up.
-458.30%
Negative 10Y net income/share CAGR while RUN is at 236.84%. Joel Greenblatt sees a major red flag in long-term profit erosion.
4.71%
Below 50% of RUN's 236.84%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-259.26%
Negative 3Y CAGR while RUN is 236.84%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-53.50%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.51%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-52.35%
Negative 3Y equity/share growth while RUN is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.82%
AR growth is negative/stable vs. RUN's 31.37%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-8.26%
Inventory is declining while RUN stands at 20.06%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.10%
Negative asset growth while RUN invests at 6.55%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.89%
We have a declining book value while RUN shows 5.64%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.11%
Debt growth far above RUN's 7.16%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.75%
R&D growth drastically higher vs. RUN's 6.09%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.44%
We cut SG&A while RUN invests at 12.43%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.